Genomics has published groundbreaking research revealing that 8% of the UK's adult population carries a polygenic risk for heart disease equivalent to that of carriers of Familial Hypercholesterolemia (FH). This polygenic group, previously undetected by the NHS, accounts for a significant portion of early heart disease cases—18 times more than those caused by FH.

We are delighted to share exciting news in cardiovascular prevention! Genomics plc's study in the European Journal of Preventive Cardiology integrates genetic risk factors for advanced heart disease prediction with QRISK®2. This HEART Study demonstrates that Integrated Risk Tools (IRTs) are a potent combination outperforming existing tools.

• Polygenic risk scores (PRS) substantially enhance risk prediction in cardiovascular disease (CVD), the #1 cause of death around the world
• These study results represent the first clinical validation of such a tool across multiple ancestries and ethnicities

• Genomics plc’s method outperforms current tools and could help save more than 2,000 lives annually in the US alone
• Opportunity to identify individuals who are at risk of heart disease and target immediate prevention

Genomics has published groundbreaking research revealing that 8% of the UK's adult population carries a polygenic risk for heart disease equivalent to that of carriers of Familial Hypercholesterolemia (FH). This polygenic group, previously undetected by the NHS, accounts for a significant portion of early heart disease cases—18 times more than those caused by FH.

We are delighted to share exciting news in cardiovascular prevention! Genomics plc's study in the European Journal of Preventive Cardiology integrates genetic risk factors for advanced heart disease prediction with QRISK®2. This HEART Study demonstrates that Integrated Risk Tools (IRTs) are a potent combination outperforming existing tools.

• Polygenic risk scores (PRS) substantially enhance risk prediction in cardiovascular disease (CVD), the #1 cause of death around the world
• These study results represent the first clinical validation of such a tool across multiple ancestries and ethnicities

• Genomics plc’s method outperforms current tools and could help save more than 2,000 lives annually in the US alone
• Opportunity to identify individuals who are at risk of heart disease and target immediate prevention

Genomics has published groundbreaking research revealing that 8% of the UK's adult population carries a polygenic risk for heart disease equivalent to that of carriers of Familial Hypercholesterolemia (FH). This polygenic group, previously undetected by the NHS, accounts for a significant portion of early heart disease cases—18 times more than those caused by FH.

We are delighted to share exciting news in cardiovascular prevention! Genomics plc's study in the European Journal of Preventive Cardiology integrates genetic risk factors for advanced heart disease prediction with QRISK®2. This HEART Study demonstrates that Integrated Risk Tools (IRTs) are a potent combination outperforming existing tools.

• Polygenic risk scores (PRS) substantially enhance risk prediction in cardiovascular disease (CVD), the #1 cause of death around the world
• These study results represent the first clinical validation of such a tool across multiple ancestries and ethnicities

• Genomics plc’s method outperforms current tools and could help save more than 2,000 lives annually in the US alone
• Opportunity to identify individuals who are at risk of heart disease and target immediate prevention